A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. (Q46019041)
Jump to navigation
Jump to search
scientific article published on 8 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. |
scientific article published on 8 May 2009 |
Statements
1 reference
A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. (English)
1 reference
Tomoko Asakawa
1 reference
Osamu Kataoka
1 reference
Nobuhiro Suzuki
1 reference
Koji Takeuchi
1 reference
Hiroyuki Odaka
1 reference
8 May 2009
1 reference
1 reference
85
1 reference
3-4
1 reference
122-126
1 reference